Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd. > Summary
Court Case Number 1:21-cv-01347
Filing Date Sep 24, 2021
Termination Date Nov 14, 2022
Court Delaware District Court
Status Dismissed - Other
Plaintiff
Defendant
Plaintiff Attorneys
12Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Nicholas N. Kallas
Venable
Novartis
Attorney Name: Christopher E. Loh
Venable
Novartis
Attorney Name: Christina A. Schwarz
Venable
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Alexandra M. Joyce
Novartis
Attorney Name: Nicholas N. Kallas
Novartis
Attorney Name: Christopher E. Loh
Novartis
Attorney Name: Christina A. Schwarz
Novartis
Attorney Name: Daniel M. Silver
Attorney Name: Jared L. Stringham
Novartis
Attorney Name: Christina A. Schwarz
Defendant Attorneys
10Crystal Pharmatech Co. Ltd.
Attorney Name: Scott A. Cunning II
Parker Poe Adams & Bernstein LLP
Crystal Pharmatech Co. Ltd.
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Crystal Pharmatech Co. Ltd.
Attorney Name: Kyle Musgrove
Parker Poe Adams & Bernstein LLP
Crystal Pharmatech Co. Ltd.
Attorney Name: Elizabeth M. Crompton
Crystal Pharmatech Co. Ltd.
Attorney Name: Scott A. Cunning II
Crystal Pharmatech Co. Ltd.
Attorney Name: Dominick T. Gattuso
Crystal Pharmatech Co. Ltd.
Attorney Name: Kyle Musgrove
Attorney Name: Kyle Musgrove
Crystal Pharmatech Co. Ltd.
Attorney Name: Scott A. Cunning II
Counter Defendant
4Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Alexandra M. Joyce
Novartis
Attorney Name: Daniel M. Silver
Counter Claimant
2Crystal Pharmatech Co. Ltd.
Attorney Name: Dominick T. Gattuso
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09937143 | Inhibitors for treating diseases characterized by atrial enlargement or remodeling | Apr 10, 2018 |
| 09517226 | Inhibitors for treating diseases characterized by atrial enlargement or remodeling | Dec 13, 2016 |
